When a company reports earnings, the reports are intensely examined by investors and analysts alike. Earnings are important because they can give insight into the profitability of a company. Covering Street analysts are looking for GlycoMimetics, Inc. (NASDAQ:GLYC) to report quarterly EPS of $-0.44. The company is next expected to publish earnings on or around 2016-11-10 for the period ending 2016-09-30.
The earnings report has the ability to trigger near-term movements of the stock whether results hit or miss expectations. Before the earnings report, investors might be watching directional trends of estimates. The company posted actual EPS for the last quarter of $-0.41. The Zacks Research consensus estimate prior to earnings was $-0.44. The difference between the two numbers was $0.03 which resulted in a surprise factor of 6.82%. 3 analysts polled by Zacks Research currently have a mean target price of $14 on the stock. The top target is presently $16 and the lowest target has the stock reaching $11 within the year. Zacks Research also uses an analyst ratings scale that spans from 1 to 5. Using this scale, a 1 would indicate a Strong Buy, and a 5 rating would represent a Strong Sell rating. Using all the ratings on GlycoMimetics, Inc. (NASDAQ:GLYC), the mean rests at 1.
Analyst recommendations and estimates are for informational purposes only and should be used along with a number of other factors when considering an investment position.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.